Marc Lustig

Marc Lustig

Chief Executive Officer at PHARMACIELO LTD.

Net worth: 7 M $ as of 2024-03-30

51 year
Finance
Process Industries
Health Technology

Profile

Marc Lustig is the founder of Cannabis Royalties & Holdings Corp.
(founded in 2016), CannaRoyalty Corp.
(founded in 2015), and Trichome Financial Corp.
(founded in 2017).
He held the titles of Chief Executive Officer & Director at Cannabis Royalties & Holdings Corp., Executive Chairman & Chief Executive Officer at CannaRoyalty Corp., and Chairman at Trichome Financial Corp.
Mr. Lustig was also the founder of Cedars Cancer Foundation.
His current jobs include Chairman & Chief Executive Officer at PharmaCielo Ltd.
(since 2020), Executive Chairman at IM Cannabis Corp.
(since 2019), Director at Cresco Labs LLC, Director at Aequus Pharmaceuticals, Inc. (since 2021), Independent Director at BriaCell Therapeutics Corp.
(since 2021), Director at Resolve Digital Health, Inc., Director at Cresco Labs, Inc. (since 2020), Director at Trichome Financial Corp.
(since 2019), Director at L5 Capital, Inc., and Director at Cresco Labs, Inc. (Arizona) (since 2021).
His former jobs included Chairman at Meta Growth Corp.
(2017-2020), Chairman at Trichome Financial Corp., Chairman at Wellfield Technologies, Inc. (2021-2023), Director at RF Capital Group, Inc., Independent Director at 22 Capital Corp., Independent Director at Planet 13 Holdings, Inc. (2018-2019), Head-Capital Markets at Merck & Co., Inc., Principal at Griffiths McBurney Corp., Head-Capital Markets at Dundee Capital Markets, Inc. (2012-2014), Sales Associate at GMP Securities LP, Vice President at Orion Securities, Inc., and Principal at KES 7 Capital, Inc.Mr. Lustig's education included a graduate degree and an MBA from McGill University.
Mr. Lustig is also the founder of Cedars Cancer Foundation.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-12-19 1,660,000 ( 10.39% ) 5 M $ 2024-03-30
2024-04-10 5,341,238 ( 3.35% ) 908 010 $ 2024-03-30
2024-03-27 930,635 ( 6.95% ) 493 237 $ 2024-03-30
2023-09-12 7,261,339 ( 4.57% ) 370 328 $ 2024-03-30
2023-06-25 6,879,725 ( 13.60% ) 213 271 $ 2024-03-30
2023-09-19 6,400,000 ( 11.40% ) 153 600 $ 2024-03-30
2023-11-01 39,184 ( 0.01% ) 81 111 $ 2024-03-30
2023-06-19 6,916,666 ( 5.21% ) 76 083 $ 2024-03-30
2023-06-28 1,589 ( 99.94% ) 3 289 $ 2024-03-30

Marc Lustig active positions

CompaniesPositionStart
IM CANNABIS CORP. Chairman 2019-10-10
PHARMACIELO LTD. Chief Executive Officer 2023-07-10
CRESCO LABS INC. Director/Board Member 2020-06-28
AEQUUS PHARMACEUTICALS INC. Director/Board Member 2021-02-14
BRIACELL THERAPEUTICS CORP. Director/Board Member 2021-08-30
TRICHOME FINANCIAL CORP. Director/Board Member 2019-09-30
Director/Board Member -
Director/Board Member -
Director/Board Member -
All active positions of Marc Lustig

Former positions of Marc Lustig

CompaniesPositionEnd
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
See the detail of Marc Lustig's experience

Training of Marc Lustig

McGill University Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Marc Lustig's experience

Connections

100 +

1st degree connections

25

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies8
MERCK & CO., INC.

Health Technology

IM CANNABIS CORP.

Health Technology

AEQUUS PHARMACEUTICALS INC.

Health Technology

RF CAPITAL GROUP INC.

Finance

PLANET 13 HOLDINGS INC.

Process Industries

CRESCO LABS INC.

Process Industries

PHARMACIELO LTD.

Process Industries

WELLFIELD TECHNOLOGIES INC.

Finance

Private companies16

Finance

Finance

Process Industries

Finance

Finance

Finance

Process Industries

Process Industries

Health Technology

Finance

Retail Trade

Finance

Cedars Cancer Foundation

Finance

Finance

BriaCell Therapeutics Corp.

See company connections